Cue Biopharma Inc buy Piper Sandler
Start price
03.04.24
/
50%
€1.66
Target price
03.04.25
€7.39
Performance (%)
-58.13%
End price
04.04.25
€0.70
Summary
This prediction ended on 04.04.25 with a price of €0.70. The BUY prediction by Piper_Sandler for Cue Biopharma Inc performed very badly with a performance of -58.13%. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cue Biopharma Inc | -10.055% | -10.055% | -55.272% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
Comments by Piper_Sandler for this prediction
In the thread Cue Biopharma Inc diskutieren
Cue Biopharma, Inc. (NASDAQ: CUE) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $8.00 price target on the stock.
Ratings data for CUE provided by MarketBeat
In the thread Trading Cue Biopharma Inc
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten